Media

GPhA: Launch of Generic Lipitor® Confirms Value of Competition In Delivering Savings and Lowering Health Care Spending 11.30.2011

GPhA Statement in Response to the Federal Trade Commission Interim Report on Authorized Generic Drugs 6.24.2009

GPhA Calls PhRMA's Authorized Generics Study "Disingenuous" 4.18.2007

GPhA Praises Bipartisan House Introduction of Bill to Block Authorized Generics During 180-Day Exclusivity Period 2.06.2007

GPhA Supports Bill to Block Authorized Generics and Restore the Value of the 180-Day Generic Exclusivity Period - Applauds Senators Rockefeller, Schumer, Leahy and Kohl for Introducing “The Fair Prescription Drug Competition Act of 2007” 1.31.2007

GPhA Praises Supreme Court Decision Allowing Swifter Resolution of Patent Disputes - Court Upholds Declaratory Judgments 1.19.2007

GPhA Praises Emerson’s House Companion Version of Rockefeller Authorized Generic Bill 8.01.2006

Independent Analysis Reveals that Authorized Generics are Bad for Consumers, Lead to Higher Pharmaceutical Prices 7.31.2006

GPhA Says Rockefeller/Schumer/Leahy Bill Will Close Authorized Generic Loophole 7.20.2006

GPhA Statement on PhRMA Assessment of Authorized Generics 6.28.2006

GPhA: Reconciliation Bill Will Bring Savings to Taxpayers Through Change in Authorized Generics Calculation 2.08.2006

GPhA Welcomes FTC's Decision to Study Authorized Generics: 'Authorized Generics' Undermine Incentive to Produce Affordable Medicines 11.09.2005

GPhA Welcomes FTC's Consideration of Authorized Generics Study: 'Authorized Generics' Undermine Incentive to Produce Affordable Medicines 5.12.2005